Benign Prostatic Hyperplasia (BPH) Surgical Treatments - (0159) — MM 0159 | CIGNA Coverage Update

Cigna modified MM 0159 for BPH surgical treatments, effective September 26, 2025. Every code in this update carries a "Not Medically Necessary" designation — here's what that means for your claims.

Cigna Healthcare updated its BPH surgical treatments coverage policy (MM 0159) to address six specific codes: CPT 0950T, 53865, 53899, 55899, 76999, and HCPCS C9769. All six land in the same bucket — considered not medically necessary for BPH treatment. If your urology or urogynecology billing team submits any of these codes against a Cigna commercial plan for BPH, expect a claim denial.

Quick-Reference: Cigna MM 0159 BPH Policy Update (2025)

Cigna BPH Surgical Treatment Coverage Criteria and Medical Necessity Requirements 2025

The Cigna BPH surgical treatments coverage policy under MM 0159 in the Cigna system draws a hard line on several emerging and device-based BPH procedures. None of the six codes in this update meet Cigna's medical necessity standard for BPH treatment. Full stop.

That's the real story here. This isn't a policy that says "covered with restrictions" or "prior authorization required." It says not medically necessary — which is a harder wall. Prior authorization won't unlock these. Meeting clinical thresholds won't unlock these. The denial will come regardless of how thorough your documentation is, because the issue isn't documentation. It's Cigna's coverage position on the procedures themselves.

The Cigna BPH coverage policy applies to both surgical and minimally invasive approaches. The six codes span a range of procedure types: transrectal HIFU ablation (CPT 0950T), temporary device insertion for ischemic remodeling (CPT 53865), temporary prostatic implant or stent with fixation (HCPCS C9769), and three unlisted procedure codes (CPT 53899, 55899, 76999) that often get used when a newer procedure doesn't yet have its own dedicated CPT.

This is a pattern worth recognizing. When Cigna lists unlisted codes — 53899 for urinary system, 55899 for male genital system, 76999 for unlisted ultrasound — alongside specific procedure codes like 0950T, they're closing the workaround. You can't bill the HIFU ablation under 0950T, and you can't re-route it through an unlisted code either.

If you're billing Cigna commercial plans for BPH and using prior authorization as your safety net, that approach doesn't apply here. There's no authorization pathway for a procedure classified as not medically necessary. Talk to your compliance officer before the September 26 effective date if you have any active cases involving these codes.

Cigna BPH Surgical Treatment Exclusions and Non-Covered Indications

Every code in MM 0159 carries the same non-coverage designation. That consistency tells you something: Cigna isn't making case-by-case distinctions based on patient severity or prior treatment failure. The procedure type itself is the deciding factor.

CPT 0950T covers transrectal HIFU ablation of benign prostate tissue. HIFU for BPH has been chasing coverage for years across multiple payers. Cigna's position here is consistent with a broader industry skepticism about HIFU outside of oncologic applications.

CPT 53865 covers cystourethroscopy with insertion of a temporary device for ischemic remodeling — essentially pressure necrosis of prostate tissue. HCPCS C9769 covers a similar cystourethroscopic approach but with a temporary prostatic implant or stent with fixation and anchorage. Both represent device-based, minimally invasive alternatives to traditional BPH surgery. Cigna isn't covering either.

The three unlisted codes — 53899, 55899, and 76999 — are the billing team's biggest exposure point. Practices sometimes default to these when a payer hasn't yet assigned a Category I CPT to a new procedure. Cigna's explicit inclusion of these codes in MM 0159 signals they're aware of that pattern and are cutting it off. If a BPH procedure generates a claim under one of these unlisted codes, the not-medically-necessary designation applies.

The real financial risk here isn't a single denied claim. It's a pattern of claims for device-based BPH procedures that accumulates into a recoupment audit. If your practice has been submitting 53865 or C9769 for Cigna patients and receiving reimbursement, that's worth a retrospective audit now — before Cigna runs one.

Coverage Indications at a Glance

Cigna BPH Surgical Treatment Billing Guidelines and Action Items 2025

CPT, HCPCS, and ICD-10 Codes for BPH Surgical Treatments Under MM 0159

The following codes appear in the actual MM 0159 policy document. All are designated not medically necessary for BPH treatment under Cigna's coverage policy. No ICD-10 codes are listed in the policy data — Cigna's non-coverage position is based on procedure type, not diagnosis specificity.

Not Covered CPT Codes — BPH Surgical Treatments (MM 0159)

Not Covered HCPCS Codes — BPH Surgical Treatments (MM 0159)

A few notes on BPH billing under this update:

CPT 0950T is the primary HIFU code. It was already a tough sell with most payers, and Cigna's explicit not-medically-necessary designation in MM 0159 removes any ambiguity for 2025 and beyond.

HCPCS C9769 is a relatively new code — it was created to capture a specific device-based cystourethroscopic procedure. Its inclusion here signals Cigna is keeping pace with device innovation and pre-emptively denying coverage before utilization patterns build up.

The three unlisted codes (53899, 55899, 76999) are worth special attention. Their presence in this policy is a message: Cigna BPH billing for novel procedures can't be rerouted through unlisted codes to avoid the not-medically-necessary designation. If you're not sure which procedure maps to which unlisted code in your claims, that's exactly the conversation to have with your compliance officer before the September 26, 2025 effective date.